KAKEN PHARMACEUTICAL CO.,LTD.

4521 TSE Pharmaceuticals Pharmaceutical
TSE Prime
¥3,830.00
-0.13%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Low debt: debt-to-equity of 0.21.
  • Current assets comfortably cover current liabilities (current ratio 4.52).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Thin interest cover: operating profit covers interest only about -20 times.
  • Return on equity is on the lower side at 1.4%.
  • Return on capital employed is on the lower side at -0.6%.
  • Net profit margin is slim at 2.8%.
  • Profit growth has been slow over five years (about -31% a year).
  • Sales growth has been slow over five years (about 0% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
1.89

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the market-value term.

Piotroski F-ScoreWeak
2 / 5

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 5 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥1,450億
Current Price¥ 3,830.00
High / Low¥ 4,445.00 / 3,540.00
Stock P/E67.572334
Book Value¥ 3,898.24
Dividend Yield4.95%
ROCE-0.57%
ROE1.40%
Debt to Equity0.21
Current Ratio4.52
P/B Ratio0.94867945
EPS¥ 56.57
PAT Margin2.79%
ICR-19.98
Compounded Sales Growth
10 Years —
5 Years 0.27%
3 Years —
TTM —
Compounded Profit Growth
10 Years —
5 Years -31.16%
3 Years —
TTM —
Stock Price CAGR
10 Years —
5 Years —
3 Years —
1 Year —
Return on Equity
10 Years —
5 Years —
3 Years —
Last Year 1.40%
Educational data only. Not a recommendation to buy, sell or hold any security.